Harald Herrmann
- Molecular Biology top 5%
- Hematology top 0.5%
- Oncology top 5%
- Immunology top 5%
- Genetics top 2%
- Co-authors
- Peter ValentKatharina BlattJohannes ZuberJames E. BradnerJunwei ShiChristopher R. VakocSabine Cerny‐ReitererMark Wunderlich
- Topics
- Chronic Myeloid Leukemia Treatments (29 papers)Acute Myeloid Leukemia Research (20 papers)Mast cells and histamine (18 papers)
- Cited by
- HematologyGeneticsMolecular Biology
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
Harald Herrmann
70 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 91
- Molecular Biology 2.1k
- Hematology 1.4k
- Oncology 647
- Immunology 610
- Genetics 533
Countries citing papers authored by Harald Herrmann
This map shows the geographic impact of Harald Herrmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harald Herrmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harald Herrmann more than expected).
Fields of papers citing papers by Harald Herrmann
This network shows the impact of papers produced by Harald Herrmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harald Herrmann. The network helps show where Harald Herrmann may publish in the future.
Co-authorship network of co-authors of Harald Herrmann
This figure shows the co-authorship network connecting the top 25 collaborators of Harald Herrmann. A scholar is included among the top collaborators of Harald Herrmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harald Herrmann. Harald Herrmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 78 | |
| 4 | 19 | |
| 5 | 23 | |
| 6 | 166 | |
| 7 | 20 | |
| 8 | 18 | |
| 9 | 44 | |
| 10 | 4 | |
| 11 | 26 | |
| 12 | 2 | |
| 13 | RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemiabreakdown → | 1438 |
| 14 | 12 | |
| 15 | 7 | |
| 16 | 27 | |
| 17 | 36 | |
| 18 | 61 | |
| 19 | 63 | |
| 20 | 22 |
About Harald Herrmann
Harald Herrmann is a scholar working on Hematology, Genetics and Immunology, having authored 72 papers that have together received 3.3k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (29 papers), Acute Myeloid Leukemia Research (20 papers) and Mast cells and histamine (18 papers). The work is most often cited by research in Hematology (1.4k citations), Genetics (533 citations) and Molecular Biology (2.1k citations). Harald Herrmann has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Peter Valent, Katharina Blatt, Johannes Zuber, James E. Bradner, Junwei Shi, Christopher R. Vakoc, Sabine Cerny‐Reiterer, Mark Wunderlich, Jun Qi and Scott W. Lowe. Their work appears in journals such as Nature, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.